Price $118.55 |
Market Cap
201.81B
|
Sector Health Care |
Div. Growth
10.30%
|
|
P/E
40.7
|
P/B
14.86
|
P/S
4.06
|
Dividend %
4.50%
|
|
P/CF
-
|
P/FCF
21.3
|
Op. Cash Flow
18.65M
|
FCF
5.4
|
|
Op. Margin
23.60%
|
Net Margin
10.10%
|
ROE
35.80%
|
ROI
12.70%
|
|
ROA
3.40%
|
EPS Growth
-48.40%
|
Current Ratio
0.8
|
Debt/Equity
593.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $68.73 | - | 2.90% | 148.62B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.95 | - | - | 1.59B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
